Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cyclerion Therapeutics, Inc.

2.64
-0.0900-3.30%
Volume:39.86K
Turnover:105.48K
Market Cap:8.47M
PE:-2.27
High:2.78
Open:2.65
Low:2.57
Close:2.73
Loading ...
May 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 27, 2021

[Rev.]Quaterly Report

Cyclerion Therapeutics, Inc.
Aug 27, 2021

[Rev.]Quaterly Report

Cyclerion Therapeutics, Inc.
Aug 27, 2021

[Rev.]Annual Report

Cyclerion Therapeutics, Inc.
Aug 19, 2021

Major Issues Report

8-K - Current report
Jul 30, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 29, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2021

Major Issues Report

8-K - Current report
Jun 25, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 07, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 04, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 04, 2021

Major Issues Report

8-K - Current report
Apr 30, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]